These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 2588925)

  • 1. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Collins VP
    Acta Cytol; 1984; 28(4):401-6. PubMed ID: 6380182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin and glial fibrillary acidic protein in human brain tumors.
    Yung WK; Luna M; Borit A
    J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M; Budka H; Rössler K; Hainfellner JA
    Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes in brain tumours. Differentiation or trapping?
    Escalone Zapata J
    Histol Histopathol; 1994 Apr; 9(2):325-32. PubMed ID: 8075493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
    Gottschalk J; Szymaś J
    Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
    Herpers MJ; Budka H
    Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GFAP in brain tumor diagnosis: possibilities and limitations.
    Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
    Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.